CD88 Antibodies

Santa Cruz Biotechnology provides a broad selection of CD88 monoclonal antibodies for advanced research in immunology and cell signaling. CD88 monoclonal antibodies are highly effective in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD88, also known as C5a receptor, plays a crucial role in the immune response by mediating the effects of the complement component C5a, which is involved in inflammation and the recruitment of immune cells. Understanding CD88 function is essential for elucidating its role in various pathological conditions, including autoimmune diseases and infections. The study of CD88 can provide insights into therapeutic targets for modulating immune responses. CD88 monoclonal antibodies enable precise detection and analysis of CD88 expression patterns across different cell types and tissues. Researchers investigating CD88 can uncover new pathways and mechanisms in immune system regulation. Santa Cruz Biotechnology CD88 monoclonal antibodies support scientists worldwide in advancing our understanding of immune system function and developing potential therapeutic strategies.